Navigation Links
DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
Date:4/2/2013

New York, NY (PRWEB) April 02, 2013

DrugRisks’ birth control resource center is announcing updated news on the site for women using the vaginal ring contraceptive NuvaRing. Recently added information shows the maker of the device, Organon, may have concealed the risk of dangerous estrogen bursts.

DrugRisks was created to improve the safety of those using popular prescription devices like NuvaRing by providing the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.

Health experts have warned that contraceptive rings like NuvaRing may have higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal rings could relate to a 2.5 to 3-fold increased risk of blood clots*.

DrugRisks also contains information showing that FDA has received over 5,300 adverse reports for women using NuvaRing devices.** Most common among the side effects were 1,177 cases of pulmonary embolism and 1,155 reports of thrombosis or deep vein thrombosis. In more than 30% of cases, patients required hospitalization, while 3% ended in death**.

Around 1,097 patients have filed a NuvaRing lawsuit so far alleging blood clots, with the cases consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. U.S. District Judge Rodney Sippel, who presides over the federal cases, recently delayed the start of the first NuvaRing trial until October 21, 2013***.

Now, DrugRisk has learned that Judge Sippel entered an order on March 5th allowing patients to introduce a study by Dr. Shelley Ann Tischkau, Ph.D., which finds that NuvaRing maker Organon may have concealed the risk of estrogen bursts in test patients to the FDA, which could contribute to the blood clot risks****.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact DrugRisks or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions patients to seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, NuvaRing side effects and litigation news related to NuvaRing and other devices, or to speak with a lawyer.

*nejm.org/doi/full/10.1056/NEJMoa1111840
**adverseevents.com/drugdetail.php?AEDrugID=4584&BrandName=NUVARING
***http://cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf
****mo.findacase.com/research/wfrmDocViewer.aspx/xq/fac.20130305_0000431.EMO.htm/qx

Read the full story at http://www.prweb.com/releases/nuvaring-side-effects/lawsuit-information/prweb10589445.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
2. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
3. Lung Cancer Asbestos Victims Center Now Urges Retired Nonsmoker Industrial Workers Who Have Been Diagnosed With Any Type Of Lung Cancer To Call Them About Compensation
4. Mesothelioma Victims Center Urges Family Members With A Parent Diagnosed With Mesothelioma To Call Them For The Contacts Of The Most Skilled Mesothelioma Law Firms
5. The Hearing Center of Lake Charles, Number One Provider of Hearing Aids in Lake Charles LA, Announces New Comparison Guide
6. Rapid Fat Loss
7. How “Final Phase Fat Loss” Helps Men Build Muscle And Burn Fat Fast – Health Review Center
8. Orthopaedic & Spine Institute Opens New Children's Center
9. Mesothelioma Victims Center Now Urges Families Dealing With A Loss From Mesothelioma To Focus On Compensation- Call Them For The Names Of Best Mesothelioma Law Firms
10. Drug Center Adds News on Mirena Lawsuits: Bayer Fighting Move to Federal Court
11. Kessler Foundation scientists receive Consortium of MS Centers grant to study emotional processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative ... National Family Partnership and the Drug Enforcement Administration as part of the National Red ... 10 winning schools who decorated their campuses with this year’s Red Ribbon Week theme: ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... they now offer a comprehensive in-house dental plan for all patients. Understanding that ... a plan that gives patients a number of perks, including discounts on many ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... Deloitte Wisconsin 75, an annual ranking and recognition of the largest closely held ... list, having ranked from 2008-2016. In addition, Standard Process was awarded the Talent ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For ... announced the opening of a new residential mental health treatment program in Chino ... issues such as severe anxiety, depression, bi-polar disorder, and other related issues. , ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... and stylish design wanted by today’s consumers at an affordable price, is now ... says the new watch is “a game changer” when it comes to the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 bioLytical Laboratories, un líder mundial en test rápidos ... HIV Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la ...
(Date:12/2/2016)... GARDENS, N.Y. , Dec. 2, 2016  LifeVac, ... will be included in the Emergency Response Training and ... are very excited to have LifeVac become part of ... Lih , Founder and CEO of LifeVac. "Having an ... LifeVac safely and effectively will help leverage our efforts ...
(Date:12/2/2016)... India , December 2, 2016 ... report "In Vitro Diagnostics/IVD Market by Product (Instruments, ... Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) ... global market is valued at USD 60.22 Billion ... at a CAGR of 5.5% during the forecast ...
Breaking Medicine Technology: